PURE Bioscience Reports Fourth Quarter and Fiscal Year 2010 Results

October 29, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fourth quarter and fiscal year ended July 31, 2010 (“Fiscal 2010”).

Twitter
LinkedIn
Facebook
Email
Print

Earnings